Back to MORGAN STANLEY MORGAN STANLEY

CTSOCTSO
Showing 8 of 9 quarters

Position history for MORGAN STANLEYMORGAN STANLEY's holdings in CYTOSORBENTS CORP

MORGAN STANLEY holds 91,338 shares of CTSO (CYTOSORBENTS CORP), worth $34,160 as of 2026-Q2. The position was decreased (-8.8% shares).

Current Value

$34,160

Current Shares

91,338

Total Value Change

-$136,809

Total Shares Change

-22,641

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
91,338
-8.8%
$34,1600.0%$0.37
0
2026-Q1
Decreased
100,169
-14.0%
$56,7260.0%$0.80
0
2025-Q4
Increased
116,480
+8.6%
$74,4550.0%$0.64
16
2025-Q3
Increased
107,256
+1.8%
$100,1880.0%$0.93
15
2025-Q2
Decreased
105,410
-0.3%
$134,9260.0%$1.23
0
2025-Q1
Decreased
105,707
-0.9%
$105,7080.0%$1.00
0
2024-Q4
Decreased
106,625
-6.5%
$97,0290.0%$0.90
0
2024-Q3
Decreased
113,979
-0.2%
$170,9690.0%$1.50
0

Other major holders of CTSO: BNP PARIBAS FINANCIAL MARKETS, Neuberger Berman Group LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used